Home
About
Services
Partners
Client Portfolio
News
Contact
China’s industrial profits grow at fastest in eight months, but sustained recovery uncertain
December 27, 2019
Oil hits three-month highs as strong U.S. consumer spending underpins growth hopes
December 27, 2019
0
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Published by
Muller&Green
at
December 27, 2019
Categories
RSS
Tags
Astellas Pharma Inc has bought U.S.-based Xyphos Biosciences Inc to expand its immuno-oncology business, a deal worth up to $665 million including potential development milestones and its second acquisition announced this month.
Powered by
WPeMatico
Muller&Green
Related posts
December 3, 2024
Why Street Cats Are Taking Over Urban Neighborhoods
Read more
December 3, 2024
TIME Is Looking For the World’s Top EdTech Companies of 2025
Read more
December 2, 2024
Intel CEO Pat Gelsinger Retires
Read more